SpectraCure AB - Asset Resilience Ratio

Latest as of December 2025: 12.95%

SpectraCure AB (SPEC) has an Asset Resilience Ratio of 12.95% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr13.53 Million

≈ $1.46 Million USD Cash + Short-term Investments

Total Assets

Skr104.47 Million

≈ $11.24 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how SpectraCure AB's Asset Resilience Ratio has changed over time. Check SpectraCure AB strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down SpectraCure AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SPEC company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr13.53 Million	12.95%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr13.53 Million	12.95%

Asset Resilience Insights

Moderate Liquidity: SpectraCure AB has 12.95% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SpectraCure AB Industry Peers by Asset Resilience Ratio

Compare SpectraCure AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for SpectraCure AB (2016–2025)

The table below shows the annual Asset Resilience Ratio data for SpectraCure AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.95%	Skr13.53 Million ≈ $1.46 Million	Skr104.47 Million ≈ $11.24 Million	-2.16pp
2024-12-31	15.10%	Skr18.27 Million ≈ $1.97 Million	Skr121.00 Million ≈ $13.02 Million	-24.22pp
2023-12-31	39.32%	Skr56.95 Million ≈ $6.13 Million	Skr144.83 Million ≈ $15.59 Million	-18.05pp
2022-12-31	57.37%	Skr93.18 Million ≈ $10.03 Million	Skr162.42 Million ≈ $17.48 Million	-10.70pp
2021-12-31	68.07%	Skr129.69 Million ≈ $13.96 Million	Skr190.52 Million ≈ $20.50 Million	-6.61pp
2020-12-31	74.69%	Skr157.24 Million ≈ $16.92 Million	Skr210.53 Million ≈ $22.66 Million	+20.58pp
2019-12-31	54.10%	Skr54.21 Million ≈ $5.83 Million	Skr100.19 Million ≈ $10.78 Million	-11.27pp
2018-12-31	65.38%	Skr45.08 Million ≈ $4.85 Million	Skr68.95 Million ≈ $7.42 Million	+48.79pp
2017-12-31	16.59%	Skr2.44 Million ≈ $262.60K	Skr14.71 Million ≈ $1.58 Million	+15.26pp
2016-12-31	1.33%	Skr381.67K ≈ $41.07K	Skr28.77 Million ≈ $3.10 Million	--

pp = percentage points

About SpectraCure AB

ST:SPEC Sweden Medical Devices

Market Cap

$1.42 Million

Skr13.15 Million SEK

Market Cap Rank

#30304 Global

#706 in Sweden

Share Price

Skr0.03

Change (1 day)

-3.31%

52-Week Range

Skr0.03 - Skr0.31

All Time High

Skr43.59